-
EP2179724
European procedure
Extract from the Register of European Patents
EP About this file: EP2179724
| EP2179724 - Tamper-resistant products for delivery of opioids and other drugs apt to be abused [Right-click to bookmark this link] | |||
| Former [2010/17] | Tamper-resistant products for opioid delivery | ||
| [2011/31] | Status | No opposition filed within time limit Status updated on 22.02.2013 Database last updated on 08.10.2024 | Most recent event Tooltip | 31.01.2020 | Change - lapse in a contracting state | published on 04.03.2020 [2020/10] | Applicant(s) | For all designated states EURO-CELTIQUE S.A. 2, avenue Charles de Gaulle 1653 Luxembourg / LU | [2010/17] | Inventor(s) | 01 /
Oshlack, Benjamin 350 South Ocean Boulevard Apartment 3D Boca Raton, FL 33432 / US | 02 /
Van Buskirk, Glenn 174 Wexford Way Basking Ridge, NJ 07920 / US | 03 /
Chasin, Mark 3 Turnburry Drive Monroe, NJ 08831 / US | 04 /
Huang, Hua-Pin 68 Birch Street Englewood Cliffs, NJ 07632 / US | 05 /
Vashi, Vijay 5 Taylor Court Ridgefield, CT 06877 / US | [2012/16] |
| Former [2010/17] | 01 /
Oshlack, Benjamin 350 South Ocean Boulevard Apartment 3D Boca Raton, FL 33432 / US | ||
| 02 /
Van Buskirk, Glenn 174 Wexford Way Basking Ridge, NJ 07920 / US | |||
| 03 /
Chasin, Mark 3 Turnburry Drive Monroe, NJ 08831 / US | |||
| 04 /
Huang, Hua-Pin 68 Birch Street Englewood Cliffs, NJ 07632 / US | |||
| 05 /
Vashi, Vijay 5 Taylor Court Ridgefield, CT 06877 / US | Representative(s) | Maiwald GmbH Elisenhof Elisenstraße 3 80335 München / DE | [N/P] |
| Former [2012/16] | Maiwald Patentanwalts GmbH Elisenhof Elisenstrasse 3 80335 München / DE | ||
| Former [2010/17] | Maiwald Patentanwalts GmbH Elisenhof Elisenstrasse 3 80335 München / DE | Application number, filing date | 10001414.1 | 19.04.2004 | [2010/17] | Priority number, date | US20030464323P | 21.04.2003 Original published format: US 464323 P | [2010/17] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP2179724 | Date: | 28.04.2010 | Language: | EN | [2010/17] | Type: | A3 Search report | No.: | EP2179724 | Date: | 27.10.2010 | [2010/43] | Type: | B1 Patent specification | No.: | EP2179724 | Date: | 18.04.2012 | Language: | EN | [2012/16] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 28.09.2010 | Classification | IPC: | A61K9/14, A61P25/04, A61K31/485, A61K45/06 | [2011/31] | CPC: |
A61K9/2081 (EP,US);
A61K9/14 (KR);
A61K31/485 (EP,US);
A61K45/06 (EP,US);
A61K9/16 (KR);
A61K9/20 (KR);
A61K9/282 (US);
A61K9/2826 (US);
A61K9/2846 (US);
A61K9/2866 (US);
A61K9/4808 (US);
A61K9/4858 (US);
A61K9/4866 (US);
A61K9/5084 (EP,US);
A61K9/5123 (US);
A61K9/5138 (US);
A61P25/00 (EP);
A61P25/04 (EP);
A61P25/36 (EP);
A61P29/00 (EP);
A61K9/1617 (EP,US);
A61K9/1635 (EP,US);
A61K9/5026 (EP,US);
A61K9/5047 (EP,US);
A61K9/5073 (EP,US)
(-)
| C-Set: |
A61K31/485, A61K2300/00 (EP,US)
|
| Former IPC [2010/17] | A61K9/14, A61P25/04, A61K31/485 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2010/17] | Extension states | AL | 11.02.2010 | HR | 11.02.2010 | LT | 11.02.2010 | LV | 11.02.2010 | MK | 11.02.2010 | Title | German: | Manipulationssichere Produkte zur Verabreichung von Opioiden und weiteren oft missbrauchten Pharmazeutika | [2011/31] | English: | Tamper-resistant products for delivery of opioids and other drugs apt to be abused | [2011/31] | French: | Produits inviolables pour l'administration d'opioïdes et d'autres composés pharmaceutiques aptes à être abusé | [2011/31] |
| Former [2010/17] | Manipulationssichere Produkte zur Verabreichung von Opioiden | ||
| Former [2010/17] | Tamper-resistant products for opioid delivery | ||
| Former [2010/17] | Produits inviolables pour administration opioïde | Examination procedure | 11.02.2010 | Examination requested [2010/17] | 09.11.2010 | Despatch of a communication from the examining division (Time limit: M04) | 07.03.2011 | Reply to a communication from the examining division | 14.07.2011 | Communication of intention to grant the patent | 07.11.2011 | Fee for grant paid | 07.11.2011 | Fee for publishing/printing paid | Parent application(s) Tooltip | EP04759980.8 / EP1615615 | Divisional application(s) | EP10009942.3 / EP2258347 | EP10010924.8 / EP2269579 | EP15181540.4 / EP3150228 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20040759980) is 27.02.2008 | Opposition(s) | 21.01.2013 | No opposition filed within time limit [2013/13] | Fees paid | Renewal fee | 11.02.2010 | Renewal fee patent year 03 | 11.02.2010 | Renewal fee patent year 04 | 11.02.2010 | Renewal fee patent year 05 | 11.02.2010 | Renewal fee patent year 06 | 11.02.2010 | Renewal fee patent year 07 | 06.04.2011 | Renewal fee patent year 08 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | |||
| Former [2013/33] | BG | 31.12.2012 | Documents cited: | Search | [AD]US5290560 (AUTANT PIERRE [FR], et al) [AD] 1-4,6-11,13-16; | [A]WO9422431 (KABI PHARMACIA AB [SE], et al) [A] 1-4,6-11,13-16; | [A]WO9818610 (LENGERICH BERNHARD H VAN [US])[A] 1-4,6-11,13-16; | [AD]US6228863 (PALERMO PHILIP J [US], et al) [AD] 1-4,6-11,13-16; | [AD]WO0158447 (EURO CELTIQUE SA [LU], et al) [AD] 1-4,6-11,13-16; | [A]US2001036476 (OSHLACK BENJAMIN [US], et al) [A] 1-4,6-11,13-16; | [A]WO02087582 (VALPHARMA SA [SM], et al) [A] 1-4,6-11,13-16; | [A]WO03007802 (EURO CELTIQUE SA [LU], et al) [A] 1-4,6-11,13-16; | [A]US2003026839 (OSHLACK BENJAMIN [US], et al) [A] 1-4,6-11,13-16; | [A]WO03013525 (EURO CELTIQUE SA [LU], et al) [A] 1-4,6-11,13-16 * page 26, lines 29-35 *; | [A]WO03013479 (EURO CELTIQUE SA [LU], et al) [A] 1-4,6-11,13-16 * page 19, paragraph 1 * | by applicant | US4293539 | US5130311 | US5266331 | US5273760 | US5286493 | US5321012 | US5324351 | US5356467 | US5409944 | US5436265 | US5472943 | US5472712 | US5475995 | US5500227 | US5502058 | US5508042 | US5510368 | US5514680 | US5521213 | US5536752 | US5549912 | US5550142 | US5552422 | US5556838 | US5580578 | US5593994 | US5604260 | US5604253 | US5616601 | US5639476 | US5639780 | US5656295 | US5681585 | WO9913799 | US6024982 | US6228863 | WO0158451 | US6277384 | US6375957 | US6475494 | - Remington's Pharmaceutical Sciences, (1980), pages 1553 - 1593 | - WEINBERG ET AL., "Sublingual Absorption of selected Opioid Analgesics", CLIN PHARMACOL THER., (1988), vol. 44, pages 335 - 340 |